NCT00343889View on ClinicalTrials.gov

Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

379

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

April 30, 2008

Conditions
DiphtheriaTetanusPertussisHepatitis BHaemophilus Infections
Interventions
BIOLOGICAL

DTaP-HB-PRP~T vaccine + OPV

0.5 mL, Intramuscular

BIOLOGICAL

Tritanrix-HepB/Hib™ + OPV vaccine

0.5 mL, Intramuscular

BIOLOGICAL

Oral Polio Vaccine

Oral co-administered with study vaccine

Trial Locations (2)

Unknown

Manila

Quezon City

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00343889 - Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine | Biotech Hunter | Biotech Hunter